Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life

Chemotherapy for end-stage cancer patients is associated with higher estimated EOL care costs. Given evidence of limited benefit and potential harm of chemotherapy for end-stage cancer patients, the cost-effectiveness of such care is questioned and further study warranted.